Strontium-Doped Hardystonite Ceramic for Load-Bearing Bone Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current orthopaedic and bone regeneration materials face challenges such as brittleness, poor mechanical strength, and limited biodegradability, which hinder their effectiveness in load-bearing applications and long-term stability, especially in areas like cortical bone, and fail to adequately promote bone tissue regeneration and vascularization.
Innovation Solution
A biocompatible strontium calcium zinc silicate material with a molecular formula of Sr0.1Ca1.9ZnSi2O7, which is synthesized using a sol-gel method, offering enhanced mechanical properties, biocompatibility, and controlled degradation, forming a hydroxyapatite layer that promotes bone integration and vascularization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional orthopaedic materials (hydroxyapatite, bioglass, calcium silicate) are used, then bioactivity and bone bonding capability are improved, but mechanical strength and fracture toughness deteriorate
Solution Approach 1:
The patent employs a composite material system consisting of strontium-doped Hardystonite ceramic combined with a biodegradable polymer matrix. This composite structure integrates the high bioactivity and bone bonding capability of the ceramic phase with the flexibility and impact resistance of the polymer phase, thereby achieving both excellent bone integration and superior mechanical strength that neither material could provide alone.
Solution Approach 2:
The patent modifies the chemical composition parameters of the Hardystonite ceramic by doping with strontium elements, which alters the crystal structure and enhances both mechanical properties (fracture toughness, strength) and biological properties (bioactivity, osteoconductivity). This parameter optimization allows the material to simultaneously achieve high mechanical strength and excellent bone bonding capability.
2Reliability
If highly porous scaffolds are created to promote bone ingrowth and vascularization, then bone regeneration capability is improved, but mechanical strength and structural integrity deteriorate
Solution Approach 1:
The patent utilizes a highly porous Hardystonite ceramic scaffold with controlled pore sizes and interconnected pore networks that facilitate bone cell infiltration, nutrient transport, and vascularization. The porous structure is optimized to provide adequate porosity for bone regeneration while maintaining sufficient structural integrity through the ceramic's inherent strength and the supporting polymer matrix.
Solution Approach 2:
The composite structure combines the rigid porous ceramic scaffold with a flexible biodegradable polymer matrix, creating a hybrid architecture where the ceramic provides structural integrity and bone conduction pathways, while the polymer fills interstices, provides toughness, and degrades over time as bone regenerates, thus maintaining structural support throughout the regeneration process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The strontium calcium zinc silicate material demonstrates improved mechanical strength, fracture toughness, and reduced corrosion, supporting bone tissue regeneration, vascularization, and long-term implant stability, while maintaining biocompatibility and minimizing fibrotic reactions, making it suitable for load-bearing applications and bone resurfacing.
Implementation Method 1
forming a hydroxyapatite layer that promotes bone integration and vascularization
Implementation Method 2
synthesized using a sol-gel method, offering enhanced mechanical properties, biocompatibility, and controlled degradation
Data Source
AI summary
The present invention relates to a biocompatible ceramic material comprising Sr, Mg or Ba doped Hardystonite (Ca2ZnSi2O7), and a method for its synthetic preparation. The present invention also relates to an implantable medical device comprising biocompatible doped Hardystonite, and a method for its production. The present invention further relates to a method for improving the long term stability of an implantable medical device and an implantable drug delivery device comprising doped Hardystonite. Further, the present invention relates to the use of comprising biocompatible doped Hardystonite in the regeneration or resurfacing of tissue.